A Randomized, Open Label, Prospective Study to Explore the Clinical Characteristics of Oral MNK155 and Norco 7.5mg/325 When Used for the Treatment of Moderate to Severe Post Operative Pain

NCT02381132 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
99
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Neil Singla

Collaborators